Iovance market cap
Web10 apr. 2024 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Iovance Biotherapeutics stock is Moderate Buy based on the current 4 hold ratings and 7 buy ratings for IOVA. The average twelve-month price prediction for Iovance … WebLearn to value Iovance Biotherapeutics, Inc. (IOVA) stock with easy-to-understand analysis. ... Here we also display the market cap and forecasted growth for additional consideration. Company PB Estimated Growth Market Cap; Peer Average: 3.1x: DVAX Dynavax …
Iovance market cap
Did you know?
WebIovance Biotherapeutics Inc (IOVA) Stock Price Today, News, Quotes, FAQs and Fundamentals 2.14% 8.50% IAS KRYS 4.70% INFY 0.46% FAST 0.66% UNL 3.55% More Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See … WebIovance Biotherapeutics (IOVA) - Revenue Global ranking Ranking by countries Ranking by categories Iovance Biotherapeutics IOVA #4382 Rank $1.23 B Marketcap 🇺🇸 USA Country $5.52 Share price -0.99% Change (1 day) -67.60% Change (1 year) 💊 Pharmaceuticals 🧬 Biotech Categories Market cap Revenue Earnings Price history P/E ratio P/B ratio More
Web29 mrt. 2024 · Iovance Biotherapeutics Inc. has a market cap of $1.45 billion and is expected to release its quarterly earnings report on May 03, 2024 – May 08, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.64, with the EPS growth for the year raised at -$2.49 for 2024 and -$2.61 for next year. WebSector Industry Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $1.160B: $0.000B: Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based …
Web13 apr. 2024 · With the market capitalization of Iovance Biotherapeutics Inc. currently standing at about $1.19 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 03, 2024 – May 08, 2024. As a result, investors might want to see an … Web10 apr. 2024 · Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. Its lead product candidate …
Web27 mei 2024 · Today Iovance can proudly say it is not an Asco faller – but only because the poor data on its cell therapy lifileucel in melanoma, which wiped 63% off the company’s market cap in early trade today, were not actually released at the meeting. Lifileucel is …
Web26 rijen · 20 mrt. 2024 · Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a … campgrounds in shelbyville ilWeb3 apr. 2024 · As of the previous market close, Iovance Biotherapeutics, Inc. has a market cap of $1.37B, which represents its share price of $6.11 multiplied by its outstanding shares number of 224.24M. first time we met anniversary quotescampgrounds in shippensburg paWebIovance Biotherapeutics Inc Share price Iovance Biotherapeutics Inc (IOVA) USD0.000041666 Sell: $7.01 Buy: $8.00 $0.32 (4.35%) Market closed Prices as at close on 21 February 2024 Turn... first time wine makingWeb13 apr. 2024 · Latest Iovance Biotherapeutics Inc Stock News. As of April 05, 2024, Iovance Biotherapeutics Inc had a $1.3 billion market capitalization, putting it in the 67th percentile of companies in the Biotechnology & Medical Research industry. Iovance … campgrounds in seward akWeb27 mrt. 2024 · Iovance Biotherapeutics Inc stock price live 5.82, this page displays NASDAQ IOVA stock exchange data. View the IOVA premarket stock price ahead of the market session or assess the after hours quote. campgrounds in seligman azWeb10 apr. 2024 · Iovance Biotherapeutics Inc's Key Ratios. Iovance Biotherapeutics Inc has a market cap of $1.33 billion, indicating a price to book ratio of 2.7741 and a price to sales ratio of 0.. In the last 12-months Iovance Biotherapeutics Inc’s revenue was $0 with a … first time worker jobs